Overview
Recepton offers biologically active proteins in stable cell lines, along with services for immune checkpoint receptors, custom-made proteins, protein analytics, organic synthesis, cell line development, and rational drug design. The company also describes case studies involving GITR/GITRL and CD82 protein production.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2018-03-16. Active
96 1020 1811 0000 0702 0338 6711
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
6 public aid cases recorded, with a total value of $2,995,076.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 30, 2026 | Aid for research and development projects: industrial research | $346.5K$346,542 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Feb 21, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $12,974$12,974 | Pomorska Specjalna Strefa Ekonomiczna sp. z o.o. | |
| Jun 1, 2019 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $628$628 | Pomorska Specjalna Strefa Ekonomiczna sp. z o.o. |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
In the case of a one-person management board, declarations of will on behalf of the company are made by the member of the management board. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make a declaration of will on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Fundacja Rodzinna Agnieszki i Adama Krzanowskich | 48 | $648.30 | 24% |
Tadeusz Holak (80) | 47 | $634.79 | 23.5% |
Monika Joanna Romanowska (54) | 42 | $567.26 | 21% |
Tomasz Sitar (47) | 47 | $634.79 | 23.5% |
Others | 16 | $216.10 | 8% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Tadeusz Holak (80)  | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| TCIsp. z o.o. | $218,471.87 | tci.pl | ||
| OPESsp. z o.o. | $100,989.20 | opes.com.pl | ||
| Countess Laboratoriessp. z o.o. | $99,221.13 | countess.pl | ||
| Xenstatssp. z o.o. | $66,774.27 | xenstats.com | ||
| Biostat Research And Developmentsp. z o.o. | $50,225.77 | biostat.com.pl | ||
| VB IdeaP.S.A. | $44,631.63 | vbidea.pl | ||
| Zawamedsp. z o.o. | $43,909.06 | zawamed.pl | ||
| Stenocoatsp. z o.o. | $36,665.21 | stenocoat.com | ||
| CannamedaiS.A. | $28,203.90 | cannamedai.com | ||
| Medaisp. z o.o. | $22,311.83 | medai.pl |
Change history
| Date | Event | |
|---|---|---|
| 2019-11-14 | Address change (Ul. Profesora Michała Bobrzyńskiego 14, 30-348, Kraków → Ul. Trzy Lipy 3, 80-172, Gdańsk) | |
| 2018-03-05 | Address change (Ul. Armii Krajowej 89/54, 30-150, Kraków → Ul. Profesora Michała Bobrzyńskiego 14, 30-348, Kraków) | |
| 2018-03-05 | Share capital change (5,000.00 PLN → 10,000.00 PLN) | |
| 2018-03-05 | PKD change (Added: 74, 96) | |
| 2016-02-08 | Entered in the register |
FAQ
Last updated: 2026-07-04